Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)

通过远程医疗和参与加强农村居民的癌症护理 (ENCORE)

基本信息

  • 批准号:
    10668344
  • 负责人:
  • 金额:
    $ 62.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-01 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

The proposed project is submitted in response to RFA-CA-18-026, providing an “IT-enabled, team-based care delivery models … to deliver comprehensive, coordinated, high-quality cancer-related care to rural low-income and/or underserved populations.” There are widening mortality disparities among rural cancer patients, particularly those who live in counties with persistent poverty, making it critical to develop interventions to improve outcomes for these patients. Therefore, the proposed study is based at seven rural hospitals in Tennessee and Mississippi, states with large rural populations encompassing a third and a half of the population, respectively. With barriers at the health system, provider and patient level, multi-level remotely-delivered interventions that enable rural patients and providers to access expertise housed at a comprehensive cancer center hold tremendous promise. Through the proposed study, we will employ a Type 1 Hybrid Effectiveness-Implementation design, which includes a traditional clinical effectiveness trial along with a process evaluation of the intervention delivery and implementation. Specifically, we will evaluate the 1) clinical effectiveness of a multi-level telehealthbased intervention for rural hospitals consisting of provider-level access to a molecular tumor board and patientlevel access to supportive care; and 2) facilitators and barriers to future larger scale dissemination and implementation of this multilevel intervention, designed to enhance quality of rural cancer care delivery. The intervention consists of non-randomized provider-level access to a tumor board which incorporates disease, patient and molecular tumor characteristics to enhance treatment options, together with randomized patient-level access to a self-management intervention versus attention control. The Consolidated Framework for Implementation Research will be used to identify barriers and facilitators. These efforts are possible due to existing community partnerships already in place, which will be leveraged to bring comprehensive care available at our cancer center to rural cancer patients and providers through telehealth. To further underscore the importance of our efforts, the Southern United States in which our academic cancer center is based has amongst the highest cancer mortality rates, and is the region of focus for this application. Our short-term goals are to explore means by which to enhance cancer care among rural cancer patients through broadly and remotely sharing expertise available at our cancer center with rural underserved communities in our region. Our long-term goals are to disseminate evidence-based strategies to improve outcomes among rural cancer patients.
拟议项目是根据 RFA-CA-18-026 提交的,旨在提供“IT 支持、基于团队的护理” 交付模式……为农村低收入人群提供全面、协调、高质量的癌症相关护理 和/或服务不足的人群。”农村癌症患者的死亡率差距不断扩大 特别是那些生活在持续贫困县的人们,因此制定干预措施以改善贫困状况至关重要 这些患者的结果。因此,拟议的研究以田纳西州的七家乡村医院为基础, 密西西比州农村人口较多,分别占总人口的三分之一和一半。 由于卫生系统、提供者和患者层面存在障碍,多层次的远程干预措施 使农村患者和提供者能够获得综合癌症中心的专业知识 巨大的承诺。通过拟议的研究,我们将采用 1 类混合有效性实施 设计,其中包括传统的临床有效性试验以及干预的过程评估 交付和实施。具体来说,我们将评估 1) 基于多级远程医疗的临床有效性 对乡村医院的干预包括提供者层面的分子肿瘤委员会和患者层面的访问 获得支持性护理; 2)未来更大规模传播的促进因素和障碍 实施这一多层次干预措施,旨在提高农村癌症护理服务的质量。这 干预包括非随机提供者级别的肿瘤委员会访问,其中包括疾病、 患者和分子肿瘤特征,以及随机患者水平,以增强治疗选择 获得自我管理干预与注意力控制。综合框架 实施研究将用于识别障碍和促进因素。这些努力之所以成为可能,是因为 现有的社区伙伴关系已经到位,将利用这些伙伴关系提供全面的护理 在我们的癌症中心,通过远程医疗向农村癌症患者和提供者提供服务。为进一步强调 我们努力的重要性,我们的学术癌症中心所在的美国南部有 癌症死亡率最高,是本应用的重点领域。我们的短期目标是 探索通过广泛和远程方式加强农村癌症患者癌症护理的方法 与我们地区服务欠缺的农村社区分享我们癌症中心的专业知识。我们的长期 目标是传播基于证据的策略,以改善农村癌症患者的治疗结果。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Enhancing Cancer care of rural dwellers through telehealth and engagement (ENCORE): protocol to evaluate effectiveness of a multi-level telehealth-based intervention to improve rural cancer care delivery.
  • DOI:
    10.1186/s12885-021-08949-4
  • 发表时间:
    2021-11-23
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Pal T;Hull PC;Koyama T;Lammers P;Martinez D;McArthy J;Schremp E;Tezak A;Washburn A;Whisenant JG;Friedman DL
  • 通讯作者:
    Friedman DL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Debra L. Friedman其他文献

Insurance, Financial Strain, Family Function, and Psychosocial Wellbeing in Pediatric Patients and Parents with Hematologic Malignancies
  • DOI:
    10.1182/blood-2024-207908
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Nadia Syed;Stacie Dusetzina;Tatsuki Koyama;Emma Schremp;Meredith Smalls;Debra L. Friedman
  • 通讯作者:
    Debra L. Friedman
Verapamil and valproic acid treatment of prolonged mania.
维拉帕米和丙戊酸治疗长期躁狂。
Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients
在发热、非严重中性粒细胞减少儿科干细胞移植患者队列中应用血流感染风险预测模型
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Kasey Jackson;Victoria Anderson;Zhiguo Zhao;C. Kitko;J. Connelly;R. Ho;Ritu Banerjee;D. Dulek;Debra L. Friedman;A. Esbenshade
  • 通讯作者:
    A. Esbenshade
Monitoring diagnostic accuracy and complications. A report from the Children's Oncology Group Hodgkin lymphoma study
  • DOI:
    10.1016/j.jpedsurg.2006.12.030
  • 发表时间:
    2007-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Peter F. Ehrlich;Debra L. Friedman;Cynthia L. Schwartz; Children Oncology Group Hodgkin Lymphoma study section
  • 通讯作者:
    Children Oncology Group Hodgkin Lymphoma study section
Comparison of outcomes, adverse events, and treatment burden of intravenous chemotherapy versus intra-arterial chemotherapy for retinoblastoma: results of a pilot study
  • DOI:
    10.1016/j.jaapos.2019.08.031
  • 发表时间:
    2019-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Pranav R. Santapuram;Jessica L. Burris;Debra L. Friedman;Tatsuki Koyama;Anthony B. Daniels
  • 通讯作者:
    Anthony B. Daniels

Debra L. Friedman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Debra L. Friedman', 18)}}的其他基金

CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
因果关系:增强对整个生命周期肉瘤幸存者的理解的队列
  • 批准号:
    10900883
  • 财政年份:
    2021
  • 资助金额:
    $ 62.21万
  • 项目类别:
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
因果关系:增强对整个生命周期肉瘤幸存者的理解的队列
  • 批准号:
    10212723
  • 财政年份:
    2021
  • 资助金额:
    $ 62.21万
  • 项目类别:
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
通过远程医疗和参与加强农村居民的癌症护理 (ENCORE)
  • 批准号:
    9788880
  • 财政年份:
    2019
  • 资助金额:
    $ 62.21万
  • 项目类别:
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
通过远程医疗和参与加强农村居民的癌症护理 (ENCORE)
  • 批准号:
    10208824
  • 财政年份:
    2019
  • 资助金额:
    $ 62.21万
  • 项目类别:
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium
视觉终点和 RB 治疗后健康结果的研究:RIVERBOAT 联盟
  • 批准号:
    9755391
  • 财政年份:
    2018
  • 资助金额:
    $ 62.21万
  • 项目类别:
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium
视觉终点和 RB 治疗后健康结果的研究:RIVERBOAT 联盟
  • 批准号:
    10473688
  • 财政年份:
    2018
  • 资助金额:
    $ 62.21万
  • 项目类别:
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium
视觉终点和 RB 治疗后健康结果的研究:RIVERBOAT 联盟
  • 批准号:
    10669063
  • 财政年份:
    2018
  • 资助金额:
    $ 62.21万
  • 项目类别:
Telephone Counseling - Caregivers for Children with Cancer
电话咨询 - 癌症儿童的护理人员
  • 批准号:
    8339427
  • 财政年份:
    2011
  • 资助金额:
    $ 62.21万
  • 项目类别:
Conducting Research in Pediatric Hematology/Oncology
进行儿科血液学/肿瘤学研究
  • 批准号:
    8547785
  • 财政年份:
    2011
  • 资助金额:
    $ 62.21万
  • 项目类别:
Core 1: PRACTICE Shared Resource Core
核心1:实践共享资源核心
  • 批准号:
    10328040
  • 财政年份:
    2011
  • 资助金额:
    $ 62.21万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.21万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了